|
End-of-day quote
Shanghai S.E.
2026-10-22
|
5-day change | 1st Jan Change | ||
| 5.560 CNY | -6.87% |
|
-10.18% | +61.16% |
| 10-13 | Harbin Pharmaceutical Subsidiary Gets China Approval for Sodium Sulfate API | MT |
| 08-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Harbin Pharmaceutical Group Co., Ltd.
| 2018-05-03 | Annual 0.5 CNY |
| 2017-04-12 | Annual 0.5 CNY |
| 2015-11-12 | Interim Payment 1 CNY |
| 2014-08-25 | Annual 0.066 CNY |
| 2011-07-31 | Annual 0.58 CNY |
| 2010-06-08 | Annual 0.49 CNY |
| 2009-07-26 | Annual 0.59 CNY |
| 2008-07-30 | Annual 0.1 CNY |
| 2004-08-12 | Annual 0.1 CNY |
| 2003-07-16 | Annual 0.12 CNY |
| 2002-07-11 | Annual 0.1 CNY |
| 2001-06-14 | Final Payment 0.15 CNY |
| 2000-07-24 | Final Payment 0.12 CNY |
| 1998-06-21 | Annual 0.12 CNY |
| 1996-08-28 | Annual 0.15 CNY |
- Stock Market
- Stocks
- 600664 Stock
- Charts Harbin Pharmaceutical Group Co., Ltd.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
